Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases

[1]  E. Wood,et al.  Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry , 2016, Internal medicine journal.

[2]  P. Coppo,et al.  [Management of thrombotic thrombocytopenic purpura in two French centers: A series of 27 patients]. , 2016, La Revue de medecine interne.

[3]  J. Sadler.  What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura. , 2015, Hematology. American Society of Hematology. Education Program.

[4]  P. Coppo,et al.  Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange. , 2015, Hematology. American Society of Hematology. Education Program.

[5]  L. Ye,et al.  Long-term remission induced by low-dose rituximab for relapsed and refractory thrombotic thrombocytopenic purpura: A report of two cases. , 2015, Experimental and therapeutic medicine.

[6]  C. Abrams,et al.  How I treat refractory thrombotic thrombocytopenic purpura. , 2015, Blood.

[7]  S. Cataland,et al.  Acquired thrombotic thrombocytopenic purpura: new therapeutic options and their optimal use , 2015, Journal of thrombosis and haemostasis : JTH.

[8]  S. Vesely,et al.  The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura. , 2015, Blood.

[9]  L. Bouillet,et al.  Prise en charge du purpura thrombotique thrombopénique dans deux centres français : à partir de 27 patients , 2015 .

[10]  H. Ha,et al.  Current status in diagnosis and treatment of hereditary thrombotic thrombocytopenic purpura. , 2015 .

[11]  A. Barrett,et al.  ST2: the biomarker at the heart of GVHD severity. , 2015, Blood.

[12]  H. Hanby,et al.  Current status in diagnosis and treatment of hereditary thrombotic thrombocytopenic purpura. , 2014, Hereditary genetics : current research.

[13]  F. Peyvandi,et al.  Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies , 2012, British journal of haematology.

[14]  B. Myers.  Diagnosis and management of maternal thrombocytopenia in pregnancy , 2012, British journal of haematology.

[15]  J. Holz.  The TITAN trial--assessing the efficacy and safety of an anti-von Willebrand factor Nanobody in patients with acquired thrombotic thrombocytopenic purpura. , 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[16]  H. Kwaan,et al.  Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura. , 2012, Blood.

[17]  K. Nollet.  Future outlook in transfusion therapy. , 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[18]  S. Held,et al.  Novel treatment concepts for graft-versus-host disease. , 2012, Blood.

[19]  [Consensus of Chinese experts on diagnosis and treatment of thrombotic thrombocytopenic purpura (version 2012)]. , 2012, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[20]  J. Voorberg,et al.  Essential Domains of A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13 Metalloprotease Required for Modulation of Arterial Thrombosis , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[21]  H. Ehrlich,et al.  Recombinant ADAMTS13 normalizes von Willebrand factor‐cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies , 2011, Journal of Thrombosis and Haemostasis.

[22]  D. Varon,et al.  Development, Cell Differentiation, Angiogenesis—Microparticles and Their Roles in Angiogenesis , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[23]  J. Segal,et al.  Thrombotic thrombocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008: clinical outcomes and risk factors for relapse , 2010, Transfusion.

[24]  M. Scully,et al.  Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura: evidence for an immunogenetic link , 2010, Journal of thrombosis and haemostasis : JTH.

[25]  C. Esmon.  The discovery of the endothelial cell protein C receptor , 2010, Journal of thrombosis and haemostasis : JTH.

[26]  Ian Mackie,et al.  Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features , 2008, British journal of haematology.

[27]  J. Plate.  Signals that maintain leukemic cell viability. , 2008, Blood.

[28]  J. Sadler.  Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. , 2008, Blood.

[29]  A. Chauhan,et al.  Systemic antithrombotic effects of ADAMTS13 , 2006, The Journal of experimental medicine.

[30]  Heather L. Van Epps.  Editing HIV to death , 2006 .

[31]  S. Vesely,et al.  The incidence of thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS‐13 deficiency , 2005, Journal of thrombosis and haemostasis : JTH.

[32]  U. Schoepf,et al.  Spiral computed tomography is the first‐line chest imaging test for acute pulmonary embolism: yes , 2005, Journal of thrombosis and haemostasis : JTH.

[33]  王兆钺,et al.  Evaluation of von Willebrand factor-cleaving protease activity in patients with thrombotic thrombocytopenic purpura , 2004 .

[34]  O. Van den Bergh,et al.  Medically unexplained dyspnea: psychophysiological characteristics and role of breathing therapy. , 2004, Chinese medical journal.

[35]  J. Moake,et al.  Recent advances in thrombotic thrombocytopenic purpura. , 2004, Hematology. American Society of Hematology. Education Program.

[36]  D. Higgs.  Gene regulation in hematopoiesis: new lessons from thalassemia. , 2004, Hematology. American Society of Hematology. Education Program.

[37]  K. Fujikawa,et al.  Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic Purpura* , 2001, The Journal of Biological Chemistry.